HealthDay on MSN16h
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...
Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA
Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...
WebMD20h
New Guidance for Patients Taking GLP-1 Drugs Before Surgery
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...
Gwinnett Daily Post22h
Georgia Has the 5th Highest Rate of GLP-1 Use in the Nation
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Oncology Nurse Advisor17h
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
Findings seen in people with type 2 diabetes. HealthDay News — Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in ...
Progyny, Inc. (PGNY) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Conference Call November 12, 2024 4:45 PM ETCompany ParticipantsJames Hart - Investor RelationsPeter Anevski ...
Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...